Stay updated on Talazoparib in DNA Repair Defects Clinical Trial
Sign up to get notified when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.

Latest updates to the Talazoparib in DNA Repair Defects Clinical Trial page
- Check4 days agoChange DetectedAdded a new Lancet Oncology TALAPRO-1 publication citation (de Bono et al., 2021) with an erratum in 2022 and updated the revision to v3.5.2. Removed the older TALAPRO-1 citation with revision v3.5.0.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedLocation entry updated from Padua, Italy, 35128 to Padova, Italy, 35128. The site name now uses the local Italian spelling.SummaryDifference0.0%

- Check25 days agoChange DetectedRemoved related topics: Prostate cancer and MedlinePlus Genetics from the related topics section.SummaryDifference0.1%

- Check33 days agoChange DetectedUpdated the Italy location listing from Napoli, Italy (80131) to Naples, Italy (80131) (Naples, 80131 added; Napoli, 80131 removed). Added related topics: Prostate cancer and MedlinePlus Genetics.SummaryDifference0.1%

- Check47 days agoChange DetectedUpdated page revision from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check54 days agoChange DetectedLocations section updated with additional sites across multiple countries, expanding the study's geographic coverage.SummaryDifference0.0%

Stay in the know with updates to Talazoparib in DNA Repair Defects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.